Insider buying last 90 days
No open-market insider purchases were filed for PG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every PG insider filing, plotted on the chart in Gekko.Open PG in Gekko
NYSE: PG
Procter & Gamble (PG) Stock Analysis & Forecast
Nov 4 close
$167.32+5.26 (+3.2%)
Gekko Brief
AI summaryNov 4 closeProcter & Gamble shares rose this week, touching a 52-week high of $167.27 and closing at $167.32, up 3.2%, as strong first-quarter fiscal 2027 results drove the move. Organic sales growth of 4.0% and core EPS of $2.00, ahead of the $1.88 estimate, were accompanied by positive analyst price target revisions. The move also coincided with broader interest in dividend-paying consumer staples names following midterm election results, alongside separate items including P&G's lobbying on the PACK Act and the naming of a former P&G healthcare executive as CEO of Align Technology.
The stock trades above both its 50-day average of $151.12 and 200-day average of $149.21, with the 50-day above the 200-day, reflecting a supportive trend. The GekkoIndex reading sits at 48.8, placing PG in the Neutral zone, down 4 over five days. Price remains 11% below Gekko Fair Value of $188.05.
The next earnings date falls on 21 January 2027, 77 days away, outside a typical 20-trading-day hold. Smart money activity over the last 90 days shows 7 Congressional buys and 0 sells. Seasonality data shows the next 20 trading days have averaged a 4.3% gain over 5 years, rising in 4 of those years. Analyst consensus stands at 11 buy and 7 hold ratings among 18 firms, with a consensus target of $173.65.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Procter & Gamble price vs fair value
Close $167.32200-day averageGekko Fair Value $188.05
Procter & Gamble quick facts
- Market cap
- $388.0B
- P/E ratio
- 24.6
- Forward P/E
- 23.3
- EPS, TTM
- $6.64
- Revenue, TTM
- $87.92B
- Profit margin
- 18.2%
- Dividend yield
- 2.66%
- Beta
- 0.36
- Volume
- 13.96M avg 10.15M
- 1-year return
- +13.0%
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±3.1%
- 50-day average
- $151.12
- 200-day average
- $149.21
- Next earnings
- Jan 21 before open
- Shares outstanding
- 2.32B
Procter & Gamble swing-trade checklist
Procter & Gamble scores 5 supportive, 1 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive1 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $167.32 is above the 50-day ($151.12) and 200-day ($149.21) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
48.8, Neutral
Reading 48.8 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
11.0% below
Price is 11% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 7 buys / 0 sales.
See smart money - Earnings risksupportive
Reports in 77 days
Next report Jan 21, 2027, 77 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+4.3% on average
From this point in the calendar, the next 20 trading days averaged +4.3% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Procter & Gamble stock chart and price history
Procter & Gamble closed at $167.32 on Nov 4, 2026, +13.0% over the past year, inside a 52-week range of $137.62 to $168.17.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +12.7%
- 3 months
- +13.8%
- 6 months
- +13.1%
- 1 year
- +13.0%
The full PG chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open PG in Gekko
Follow Procter & Gamble through every session
Put PG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track PG in GekkoFree for 7 days. No credit card required.
About Procter & Gamble
Procter & Gamble makes and markets a wide range of branded household and personal items sold to consumers around the world. Its shelves span hair care, skin care and grooming names such as Pantene, Olay, Gillette and Venus, alongside oral care and health items like Crest, Oral-B, Pepto-Bismol and Vicks. The company is also known for laundry and home cleaning brands including Tide, Downy, Dawn and Swiffer, plus paper and family care products such as Pampers, Always, Bounty and Charmin.
The business is organized into five segments covering beauty, grooming, health care, fabric and home care, and baby, feminine and family care, each built around its own set of brand names. Products reach shoppers through a wide mix of channels, including large retailers, grocery and club stores, pharmacies, department stores, specialty beauty and electronics outlets, wholesalers and distributors, professional cleaning channels, e-commerce, and direct sales to consumers.
Procter & Gamble shares trade on the NYSE under the ticker PG.
- Listed
- NYSE
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Website
- pginvestor.com
Procter & Gamble GekkoIndex: the smart money zone
Procter & Gamble’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.8, in the Neutral zone, down 4 points over five sessions.
48.8Neutral
Down 4 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +2.2% | +4.0% | ||
| Accumulation | 236 | +0.4% | +0.8% | ||
| Neutral (current zone) | 404 | −0.2% | −0.5% | ||
| Distribution | 29 | −0.4% | −1.0% | ||
| Selling | 2 | Too few readings yet | |||
Average PG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the PG price, zone by zone.Track PG in Gekko
Is Procter & Gamble stock overvalued? Gekko Fair Value
Procter & Gamble trades 11.0% below Gekko Fair Value of $188.05, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Procter & Gamble shares are worth, recalculated every trading day.
$188.05
Gekko Fair Value, Nov 4, 2026
11.0% Undervalued
At the end of Aug 2026 the price was 20.4% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open PG in Gekko
Procter & Gamble insider and Congress trading
No open-market insider purchases were filed for Procter & Gamble, and members of Congress disclosed 7 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
7trades disclosed: 7 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 25 |
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 11 |
| David Taylor House, OH, purchase | $1,001 - $15,000 | Sep 18 traded Sep 8 |
| Lloyd Doggett House, TX, purchase | $1,001 - $15,000 | Sep 9 traded Aug 17 |
| Lloyd Alton Doggett House, TX, purchase | $1,001 - $15,000 | Sep 9 traded Aug 16 |
From congressional disclosures, which report amounts as ranges.
Buybacks
Procter & Gamble has been buying back its own shares.
- Bought back, quarter ended Sep 30, 2026
- $1.25B
- As a share of market cap
- 0.32%
- Trailing four quarters
- $5.03B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds PG.
0added0opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Procter & Gamble earnings: next date and track record
Procter & Gamble reports on Jan 21, 2027, before the open (77 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Jan 21, 2027
Expected before the open, 77 days away
- EPS estimate
- $1.81
- Revenue estimate
- $22.85B
8 of 8reports beat the EPS estimate
±2.4%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Oct 22, 2026 AI summary
- What they said
- P&G reported Q1 fiscal 2027 organic sales growth of 4.0%, driven by volume up 2.4 points, pricing up 0.4 points, and mix up 1 point. All 10 product categories and all 6 geographic regions grew organic sales. Core EPS was $2.00, up 1% year-over-year, though core gross margin declined 150 basis points and operating margin fell 80 basis points due to commodity, energy, and freight headwinds. Free cash flow productivity was 93%, with $3.9 billion returned to shareholders.
- Guidance
- Management confirmed the company remains on track to deliver within full fiscal year 2027 guidance ranges despite expecting commodity and freight headwinds to increase in coming quarters. No specific EPS or revenue targets were revised in this excerpt.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 22, 2026 | $2.00 est $1.88 | $23.28B est $22.80B | +2.6% |
| Jul 29, 2026 | $1.43 est $1.41 | $21.20B est $21.38B | −3.3% |
| Apr 24, 2026 | $1.59 est $1.56 | $21.24B est $20.53B | +1.8% |
| Jan 22, 2026 | $1.88 est $1.86 | $22.21B est $22.30B | +2.8% |
| Oct 24, 2025 | $1.99 est $1.90 | $22.39B est $22.18B | −0.3% |
| Jul 29, 2025 | $1.48 est $1.42 | $20.89B est $20.84B | −2.7% |
| Apr 24, 2025 | $1.54 est $1.52 | $19.78B est $20.15B | −2.8% |
| Jan 22, 2025 | $1.88 est $1.86 | $21.88B est $21.58B | +2.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Procter & Gamble stock forecast and analyst price targets
Analysts’ average 12-month price target for Procter & Gamble is $173.65, +3.8% from the last close, from 18 firms rating the stock in the last 90 days.
$173.65consensus 12-month target, +3.8% from the last close
Now $167.32Avg $173.65
Low $143High $190
Each firm’s latest rating in the last 90 days: 18 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 3 | Bernstein | $170 | +1.6% |
| Oct 26 | Piper Sandler | $167 | −0.2% |
| Oct 26 | Barclays | $165 | −1.4% |
| Oct 23 | Deutsche Bank | $176 | +5.2% |
| Oct 23 | Freedom Capital Markets | $176 | +5.2% |
−0.5%average 20-day move after past Neutral readings
+4.3%average move over the next 20 trading days in the last 5 years
±2.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Procter & Gamble seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Procter & Gamble averaged +4.3% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.6% | 5 of 5 |
| Next 10 trading days | +2.3% | 4 of 5 |
| Next 15 trading days | +3.9% | 5 of 5 |
| Next 20 trading days | +4.3% | 4 of 5 |
| Next 30 trading days | +4.3% | 4 of 5 |
For scale, PG’s typical 20-trading-day move in either direction is about 3.1%.
Procter & Gamble market cap and key statistics
Procter & Gamble’s market cap is $388.0B, with a P/E ratio of 24.6 and revenue of $87.92B over the last twelve months.
Valuation
- Market cap
- $388.0B
- P/E ratio
- 24.6
- Forward P/E
- 23.3
- EPS, TTM
- $6.64
- Gekko Fair Value
- $188.05
Trading
- Volume
- 13.96M
- Avg volume, 20 days
- 10.15M
- 52-week high
- $168.17
- 52-week low
- $137.62
- Shares outstanding
- 2.32B
Financials
- Revenue, TTM
- $87.92B
- Profit margin
- 18.2%
- Return on equity
- 29.6%
- Quarterly earnings growth, YoY
- +0.8%
Risk and income
- Beta
- 0.36
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±3.1%
- Dividend yield
- 2.66%
Procter & Gamble stock news this week
Coverage of Procter & Gamble this week reads positive: 11 positive, 5 neutral and 4 negative headlines.
- Here’s Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election ResultsThe Globe and Mail, Nov 4
- P&G lobbies on PACK ActLegis1, Nov 4
- Procter & Gamble Co Stock (PG) Moved Up by 3.17% on Nov 4: Facts Behind the MovementTradingKey, Nov 4
- Ursula Burns, Karen S. Carter, Black Enterprise, and Procter & Gamble Honored at BECA 2026 Manifest AwardsThe Citizen Newspaper Group, Nov 4
- Procter & Gamble stock hits 52-week high at 167.27 USDInvesting.com, Nov 4
- Here's Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election ResultsThe Motley Fool, Nov 4
Procter & Gamble peers
Procter & Gamble’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| CLColgate-Palmolive | Neutral | 11.8% below |
| ELEstee Lauder Companies | Neutral | 17.4% above |
| KVUEKenvue | Neutral | 15.5% below |
| KMBKimberly-Clark | Neutral | 10.8% below |
| CHDChurch & Dwight | Neutral | 4.6% above |
| CLXClorox | Distribution | 37.3% below |
A peer links to its own page where one exists.
Procter & Gamble stock FAQ
What is Procter & Gamble’s market cap?
Procter & Gamble’s market cap is $388.0B at the Nov 4, 2026 close of $167.32, with 2.32B shares outstanding. The shares trade on a P/E ratio of 24.6.
What is the Procter & Gamble stock forecast?
The consensus analyst 12-month price target for Procter & Gamble is $173.65, +3.8% from the last close. Of the 18 firms that rated the stock in the last 90 days, 11 rate it a buy, 7 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Procter & Gamble stock overvalued or undervalued?
On Gekko’s estimate Procter & Gamble is undervalued: the Nov 4, 2026 close of $167.32 is 11.0% below Gekko Fair Value of $188.05. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Procter & Gamble report earnings next?
Procter & Gamble is expected to report on Jan 21, 2027, before the market opens (77 days away). Analysts expect earnings of $1.81 per share on revenue of $22.85B. Procter & Gamble beat the earnings estimate in 8 of its last 8 reports, moving 2.4% on average across the report.
What is Procter & Gamble’s 52-week high and low?
Procter & Gamble’s 52-week high is $168.17 and its 52-week low is $137.62; it closed at $167.32 on Nov 4, 2026, +13.0% over the past year. Over the last five years the shares peaked at $180.43 on Nov 27, 2024.
Is Procter & Gamble stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (trend, fair value, smart money, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Procter & Gamble the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.